Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2016 1
2017 1
2018 4
2019 2
2020 2
2021 2
2022 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T; ATB200-07 Study Group. Schoser B, et al. J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
Kishnani PS, Byrne BJ, Claeys KG, Díaz-Manera J, Dimachkie MM, Kushlaf H, Mozaffar T, Roberts M, Schoser B, Hummel N, Kopiec A, Holdbrook F, Shohet S, Toscano A; PROPEL Study Group. Kishnani PS, et al. J Patient Rep Outcomes. 2024 Nov 13;8(1):132. doi: 10.1186/s41687-024-00805-w. J Patient Rep Outcomes. 2024. PMID: 39535661 Free PMC article. Clinical Trial.
Recurrent Guillain-Barré Syndrome - Case Series.
Basta I, Bozovic I, Berisavac I, Stojiljkovic-Tamas O, Rajic SL, Dominovic-Kovacevic A, Stojanov A, Djordjevic G, Jovanovic D, Peric S. Basta I, et al. Among authors: dominovic kovacevic a. Neurol India. 2019 Nov-Dec;67(6):1536-1538. doi: 10.4103/0028-3886.273649. Neurol India. 2019. PMID: 31857555 Free article.
Three-Year Follow-Up Study in Patients with Guillain-Barré Syndrome.
Martic V, Bozovic I, Berisavac I, Basta I, Peric S, Babic M, Rajic SL, Bjelica B, Stojiljkovic Tamas O, Stojanov A, Grunauer M, Cobeljic M, Komatina N, Djuric V, Petrovic M, Vujovic B, Dominovic Kovacevic A, Djordjevic G, Jovanovic D, Stevic Z. Martic V, et al. Among authors: dominovic kovacevic a. Can J Neurol Sci. 2018 May;45(3):269-274. doi: 10.1017/cjn.2018.12. Can J Neurol Sci. 2018. PMID: 29756592
Guillain-Barré syndrome in the elderly.
Peric S, Berisavac I, Stojiljkovic Tamas O, Rajic S, Babic M, Cvijanovic M, Dominovic-Kovacevic A, Basta I, Beslac-Bumbasirevic L, Lavrnic D. Peric S, et al. Among authors: dominovic kovacevic a. J Peripher Nerv Syst. 2016 Jun;21(2):105-10. doi: 10.1111/jns.12163. J Peripher Nerv Syst. 2016. PMID: 26880714
Frequency and features of the central poststroke pain.
Vukojevic Z, Dominovic Kovacevic A, Peric S, Grgic S, Bjelica B, Basta I, Lavrnic D. Vukojevic Z, et al. Among authors: dominovic kovacevic a. J Neurol Sci. 2018 Aug 15;391:100-103. doi: 10.1016/j.jns.2018.06.004. Epub 2018 Jun 12. J Neurol Sci. 2018. PMID: 30103954
Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B, Basta I, Bozovic I, Kacar A, Nikolic A, Dominovic-Kovacevic A, Vukojevic Z, Martic V, Stojanov A, Djordjevic G, Petrovic M, Stojanovic M, Peric S. Bjelica B, et al. Among authors: dominovic kovacevic a. J Peripher Nerv Syst. 2018 Sep;23(3):178-182. doi: 10.1111/jns.12281. Epub 2018 Jul 29. J Peripher Nerv Syst. 2018. PMID: 29999199
14 results